A case control study of proximal calciphylaxis von Bleyer, AJ, Choi, M, Igwemezie, B, de la Torre, E, White, WL

Volltext

Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5 von FIELDS, S. Z, IGWEMEZIE, L. N, LANGER, C. J, O'DWYER, P, SANJEEV KAUL, SCHACTER, L. P, SCHILDER, R. J, LITAM, P. P, HIMPLER, B. S, MCALEER, C, WRIGHT, J, BARBHAIYA, R. H

Volltext

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study von CHABOT, G. G, ARMAND, J.-P, BONNAY, M, TERRET, C, DE FORNI, M, ABIGERGES, D, WINOGRAD, B, IGWEMEZIE, L, SCHACTER, L, KAUL, S, ROPERS, J

Volltext

Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481) von Millward, M.J., Newell, D.R., Mummaneni, V., Igwemezie, L.N., Balmanno, K., Charlton, C.J., Gumbrell, L., Lind, M.J., Chapman, F., Proctor, M., Simmonds, D., Cantwell, B.M.J., Taylor, G.A., McDaniel, C., Winograd, B., Kaul, S., Barbaiya, R.H., Calvert, A.H.

Volltext

Etoposide phosphate (EP): A comparative intrapatient bio-equivalence study with etoposide(E) von Bailey, N, Millward, MJ, Newell, DR, Charlton, CJ, Gumbrell, LA, Lind, MJ, Dore-Green, F, Proctor, M, Simmonds, D, McDaniel, C, Winograd, B, Igwemezie, LN, Calvert, AH

Volltext